Autoantibodies in juvenile dermatomyositis

Area of Science:

• Immunology
• Pediatric Rheumatology

Background:

• Juvenile dermatomyositis (JDM) is an idiopathic inflammatory myopathy affecting children.
• Autoantibodies play a crucial role in the pathogenesis and diagnosis of autoimmune diseases.

Purpose of the Study:

• To investigate the prevalence of various serum autoantibodies in patients with JDM.
• To evaluate the diagnostic sensitivity of different substrates for antinuclear antibody (ANA) detection in JDM.
• To explore potential associations between autoantibodies and clinical manifestations, particularly vascular complications.

Main Methods:

• Serum samples from 14 JDM patients were analyzed for a panel of autoantibodies including ANA, anti-dsDNA, anti-histones, anti-Sm, anti-RNP, anti-SSA/SSB, anti-PM-1, anti-Jo-1, anti-mitochondrial, anti-smooth muscle, anti-gastric parietal cells, anti-cardiolipin (ACA), and rheumatoid factor.
• ANA detection was performed using both rat liver and HEp-2 cell substrates.
• Clinical data, including the presence of vascular complications, were correlated with autoantibody findings.

Main Results:

• All patients were negative for most tested autoantibodies, with positivity observed only for ANA and ACA.
• ANA were detected in 50% of patients using rat liver substrate, but sensitivity increased to 86% when HEp-2 cells were used.
• Three patients tested positive for ACA; two of these experienced vascular complications, suggesting a potential link.

Conclusions:

• HEp-2 cells are a more sensitive substrate for ANA detection in JDM compared to rat liver.
• The presence of ACA in JDM patients may be associated with an increased risk of vascular complications.
• Further research is warranted to elucidate the role of ACA in the pathogenesis of vascular disease in JDM.